Now the class of thiazolidinediones (TZDs) are the main agents for the treatment of type 2 diabetes in clinical by an insulin sensitizing mechanism.

• 噻唑烷二酮类药物(thiazolidinediones, TZDs)是近年来新研制开发得很有前途的胰岛素增敏剂，是目前临床上治疗2型糖尿病的主要药物。